CD Biosynsis offers specialized Contract Research Services (CRS) , providing fully customized R&D support across the Synthetic Biology and Protein Engineering domains. Our CRS model allows academic labs, startups, and large corporations to leverage our advanced technical platforms and expert scientific team without the need for significant internal infrastructure investment. We manage the entire research lifecycle, from initial concept development and experimental design through execution, data analysis, and final IP protection and Technology Transfer . Whether you require focused expertise in a single area or a multi-year Collaborative Research Project , our services are designed to be flexible, confidential, and goal-oriented.
Get a QuoteOutsourcing research to a dedicated CRO like CD Biosynsis provides several critical advantages: 1) Access to Expertise: Immediate deployment of specialized scientific knowledge (Metabolic Engineering, CRISPR Editing) and state-of-the-art equipment; 2) Accelerated Timeline: Dedicated resources focused solely on your project accelerate milestones; and 3) Cost Efficiency: Converting fixed overhead costs into variable project expenditures. Our CRS model focuses on delivering actionable results and proprietary technology ready for scale-up or clinical transition.
Tailored Design-Build-Test-Learn (DBTL) projects in pathway engineering, genetic circuit design, and chassis optimization.
Long-term, strategic partnerships involving shared goals, milestones, and resource allocation across multiple phases.
Custom Protein Engineering CRS
Contract research focused on the design, directed evolution, and HTS for novel enzymes, antibodies, or therapeutic proteins.
Strategic guidance on patent landscape analysis, freedom-to-operate, and IP strategy development for synthetic biology assets.
Seamless transfer of optimized strains, engineered cell lines, protocols, and documentation to your internal team or manufacturing partner.
Confidentiality & Data Security
Strict Confidentiality Agreements (CDA) and secure data handling protocols to protect your proprietary research information.
Our structured process ensures clear communication, defined milestones, and successful project outcomes.
Initial Consultation & SOW
Project Execution & Milestones
Reporting & IP Management
Technology Transfer & Handover
Detailed discussion of project goals, technical requirements, and target metrics.
Statement of Work (SOW): Formal document outlining objectives, methods, deliverables, and timelines.
Establishment of a strict CDA and defining IP ownership terms.
Dedicated project team assigned, utilizing our DBTL or R&D platform.
Regular communication (weekly/bi-weekly reports) and teleconferences for transparent progress tracking.
Validation of predetermined technical milestones and go/no-go decisions.
Transfer of all physical deliverables (plasmids, cell lines, optimized protocols, final compounds).
Post-project support and training for your internal team to ensure seamless adoption of the new technology.
Scientific Depth & Breadth
Deep expertise in both Synthetic Biology (Pathway Design) and Protein Engineering (Directed Evolution) for integrated solutions.
Risk & Cost Management
Defined project scope (SOW) and milestone-based payments minimize financial risk and ensure goal alignment from the start.
Focus on IP Strategy
Consulting and documentation structured to support robust patent applications and protect the commercial value of the delivered assets.
Seamless Technology Transfer
Structured protocols and dedicated training ensure smooth and rapid transfer of the engineered solution into your internal manufacturing or research workflow.
"Our long-term Collaborative Research Project with CD Biosynsis allowed us to establish a novel biosynthetic route to a high-value chemical. Their expertise in Metabolic Engineering and rigorous milestone reporting were key to our success."
Dr. Richard Klein, CEO, Specialty Chemicals Startup
"The Technology Transfer process was flawless. They not only delivered the optimized strain but also provided detailed training and protocols, allowing our internal team to immediately take over the manufacturing process seamlessly."
Ms. Janet Wu, VP of Manufacturing Operations
"The IP team provided invaluable Intellectual Property Consulting on our newly engineered enzyme, helping us refine our patent claims and understand the global freedom-to-operate landscape before we launched our product."
Mr. David Cho, General Counsel, Biologics Division
"We commissioned CD Biosynsis to support an intricate gene editing project with multiple targets. Their talent in producing high-quality work in a short period of time was impressive. Their solutions were custom made to suit our needs, and they went above and beyond to ensure our experiments worked. Their support has been a great asset to our research department and we look forward to further working with them."
Dr. Raj Patel, Principal Investigator, Department of Molecular Biology
"As a pharmaceutical company working to discover new cancer therapies, we require accurate, trustworthy gene editing solutions. CD Biosynsis did more than what we expected when it came to providing strong, accurate CRISPR/Cas9 solutions for our preclinical research. Their technical support team was excellent and responsive, and they quickly replied to our questions. This alliance has been pivotal in helping us move our drug pipeline forward. Thank you, CD Biosynsis, for your amazing service!"
Dr. Clara Rodriguez, Chief Scientist, AstraZeneca Pharmaceuticals, Spain
What is the typical starting point for a Collaborative Research Project ?
Collaborative projects begin with a shared R&D question or goal, often requiring expertise across multiple disciplines (e.g., AI-driven Design followed by Metabolic Engineering). We establish a detailed SOW that defines long-term objectives, resource commitments, and phased milestones.
How is my Intellectual Property (IP) protected?
We strictly adhere to a robust CDA (Confidentiality Agreement) signed before any technical discussion. IP ownership is typically defined upfront in the SOW , often vesting the client with the IP generated from the contract research, supported by our strategic IP consulting.
What does Technology Transfer involve?
Technology Transfer is the final handover process. It includes the physical transfer of all materials (plasmids, strains, purified proteins), detailed standard operating procedures (SOPs), raw and analyzed data, and dedicated training sessions for your technical staff to ensure they can reproduce and scale the results.
What is the difference between CRS and a standard Service ?
A standard Service is transactional (e.g., providing Custom Gene Synthesis). CRS is a strategic partnership focused on solving complex, multi-faceted R&D challenges, often involving multiple technologies, IP strategy, and long-term project management.
How much does Metabolic Engineering services cost?
The cost of Metabolic Engineering services depends on the project scope, complexity of the target compound, the host organism chosen, and the required yield optimization. We provide customized quotes after a detailed discussion of your specific research objectives.
Do your engineered strains meet regulatory standards?
We adhere to high quality control standards in all strain construction and optimization processes. While we do not handle final regulatory approval, our detailed documentation and compliance with best laboratory practices ensure your engineered strains are prepared for necessary regulatory filings (e.g., GRAS, FDA).
What to look for when selecting the best gene editing service?
We provide various gene editing services such as CRISPR-sgRNA library generation, stable transformation cell line generation, gene knockout cell line generation, and gene point mutation cell line generation. Users are free to select the type of service that suits their research.
Does gene editing allow customisability?
Yes, we offer very customised gene editing solutions such as AAV vector capsid directed evolution, mRNA vector gene delivery, library creation, promoter evolution and screening, etc.
What is the process for keeping data private and confidential?
We adhere to the data privacy policy completely, and all customer data and experimental data are kept confidential.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
|
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.